Author:
Amini-Farsani Zeinab,Sangtarash Mohammad Hossein,Shamsara Mehdi,Teimori Hossein
Funder
This work was supported by Shahrekord University of Medical Sciences, Shahrekord, Iran
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology
Reference32 articles.
1. Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP (2006) Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Res 66:5582–5591
2. Atlanta GA (2013) American Cancer Society. Cancer facts and figures 2013.
http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013
3. Cai Y, Tan X, Liu J, Shen Y, Wu D, Ren M, Huang P, Yu D (2014) Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro. Chin J Cancer Res 26:564–572
4. Cai G, Qiao Sh, Chen K (2015) Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B. Biol Res 48:37
5. Chatterjee A, Chattopadhyay D, Chakrabarti G (2014) MiR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression. PLoS ONE 9:e95716
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献